The evidence for fecal microbiota transplantation efficacy in liver disease continues to emerge
Read a comprehensive overview of the current state of play here:
journals.lww.com/cld/fulltex…
A succinct review on management of hepatitis B reactivation. Risks and decision for prophylaxis are based on serologic status of patients and type of immunosuppressive therapy.
Helpful figure to guide decision making.
journals.lww.com/cld/fulltex…
The role of immunotherapy in the evolving landscape of HCC treatment in the context of liver transplant.
Promising use needs to be balanced with allograft rejection
Expert opinion suggest a minimal of 12-week washout, more data needed
journals.lww.com/cld/fulltex…
The most in-depth and interesting article on the evolution of the Cardio-Hepatology field, a truly unique relationship:
journals.lww.com/cld/fulltex…
See the entire series of History of Hepatology collection here:
journals.lww.com/cld/fulltex…
@RobertFontanaMD & colleagues @MichiganLiver guide us through the challenging (& common) scenario of how to establish a diagnosis of DILI in patients on chemotherapy in a stepwise fashion
A case of PKI-associated cholestatic granulomatous hepatitis:
journals.lww.com/cld/fulltex…
Metabolic Disorders play an important role in modifying hepatitis B outcomes
From our upcoming "Current Challenges in the Management of Chronic Hepatitis B Infection" series collection:
journals.lww.com/cld/fulltex…
Check out this review and interview with the author on inpatient management of fluid overload in patients with decompensated cirrhosis.
journals.lww.com/cld/fulltex…